learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
forResearch
5 / 1000+ resultsresearch Grand Challenges in Dermatologic Drug Discovery: Four Priorities to Transform Skin Disease Treatment
Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.
research Machine Learning Algorithms as Tools for Identifying Predictive Autoantibody Biomarkers in Pemphigus Vulgaris
Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.
research Long-lived proteins and DNA as candidate predictive biomarkers for tissue associated diseases
research A Prostaglandin D-Synthase-Positive Mast Cell Gradient Characterizes Scalp Patterning
Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.
research Non-Invasive Human Skin Transcriptome Analysis Using mRNA in Skin Surface Lipids
A new non-invasive method can analyze skin mRNA to understand skin diseases better.
Community Join
5 / 126 resultscommunity Solving Hair Loss with Research at MIT
Hair loss treatments like minoxidil, finasteride, TDM-105795, and PP405. MIT is hosting a hackathon to find innovative hair loss solutions.
community Dutasteride thins eyebrows and facial hair but doesn't stop scalp loss.
Dutasteride may not effectively stop scalp hair loss and can cause thinning of facial and body hair, including eyebrows. Users suggest considering other causes like autoimmune conditions or vitamin deficiencies and exploring treatments like finasteride or minoxidil.
community Japan-led "Third Cell" Discovery: Is this the missing link for full follicle regeneration?
A new "third cell" discovery in Japan could be key to fully regenerating hair follicles, with human trials possibly starting in 2027-2028. AI is expected to accelerate medical discoveries, potentially leading to a hair loss cure within a few years.
community what is a realistic timeline when does hmi-115 gets released? What are they doing in the non-clinical dev. phase?
Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. HMI-115 release timeline is uncertain, with possible grey market availability in 2024-2025.
community Debunking the "Adverse metabolic consequences of dutasteride"
Dutasteride is more effective than finasteride, has neuroprotective benefits, and may prevent acne. Despite initial concerns about metabolic effects, further research suggests it is safe for most users, especially if not hypogonadal.